T Lymphoblastic Lymphoma: Clinical Trials

6 trials for T Lymphoblastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 11Active not recruiting 1
Phase 31Not yet recruiting 1

Follow T Lymphoblastic Lymphoma: new trials by email Literature Review of T Lymphoblastic Lymphoma trials Research Report on T Lymphoblastic Lymphoma

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma
Phase 2 / Phase 3Not yet recruitingChildren's Oncology Group17082026-08-282026-07-30
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Phase 2WithdrawnNational Cancer Institute (NCI)2024-08-092024-05-17
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
AKR1C3-activated Prodrug AST-3424, Biopsy Procedure, Biospecimen Collection - Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingSWOG Cancer Research Network672021-02-082026-09-01
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Asparaginase, Cyclophosphamide, Doxorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 2WithdrawnUniversity of Washington2018-07-012018-11-14
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission
Phase 2TerminatedFred Hutchinson Cancer Center462010-05-192023-01-23
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Cyclophosphamide, Cytarabine, Dexamethasone - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Phase 2RecruitingM.D. Anderson Cancer Center1602007-07-112026-10-08

Narrower conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (6)  ·  Burkitt Lymphoma (2)  ·  Lymphoma (2)  ·  Hodgkin Disease (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Leukemia (6)  ·  Leukemia, Lymphoid (6)  ·  Lymphatic Diseases (6)  ·  Lymphoproliferative Disorders (6)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  DNA Virus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Herpesviridae Infections (2)  ·  Infections (2)

Interventions

Cyclophosphamide (5)  ·  Doxorubicin (4)  ·  Vincristine (4)  ·  Asparaginase (3)  ·  Biopsy (3)  ·  Calcium Dobesilate (3)  ·  Cytarabine (3)  ·  Dexamethasone (3)  ·  Mercaptopurine (3)  ·  Methotrexate (3)  ·  Prednisone (3)  ·  Specimen Handling (3)  ·  auricularum (3)  ·  deltacortene (3)  ·  dexamethasone 21-phosphate (3)

Sponsors

Children's Oncology Group (1)  ·  Fred Hutchinson Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  SWOG Cancer Research Network (1)  ·  University of Washington (1)

Countries

United States (4)

Top investigators

Anjali S Advani (1)  ·  Farhad Ravandi-Kashani (1)  ·  Keith J August (1)  ·  Kristen M O'Dwyer (1)  ·  Rachel B. Salit (1)  ·  Ryan Cassaday (1)

NIH funding

U10CA180888 (2), P30CA015704 (1), U10CA180886 (1)